Catalent, Inc.·4

Aug 3, 4:09 PM ET

Arnold Jonathan 4

4 · Catalent, Inc. · Filed Aug 3, 2023

Insider Transaction Report

Form 4
Period: 2023-08-01
Arnold Jonathan
President, Oral Drug Delivery
Transactions
  • Sale

    Common Stock

    2023-08-01$47.80/sh62$2,96455,896 total
Footnotes (2)
  • [F1]Shares sold by the reporting person through an automatic "sell-to-cover" transaction to cover tax withholding obligations in connection with the vesting of restricted stock units received pursuant to the Issuer's long-term incentive plan. No shares were withheld by or surrendered to the Issuer.
  • [F2]Includes restricted stock units.

Documents

1 file
  • 4
    wf-form4_169109333979778.xmlPrimary

    FORM 4